|
|
||||||||
Eur J Cardiothorac Surg 2002;22:521-526
© 2002 Elsevier Science NL
a Department of Cardiac Surgery, Catholic University, Rome, Italy
b Department of Cardiology, Catholic University, Rome, Italy
c Angela Valenti Laboratory of Genetic and Enviromental Risk Factors for Thrombotic Disease, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
d Department of Cardiac Anaesthesiology, Catholic University, Rome, Italy
Received 27 March 2002; received in revised form 4 July 2002; accepted 11 July 2002.
* Corresponding author. Divisione di Cardiochirurgia, Policlinico Universitario A. Gemelli, Largo A. Gemelli 8, 00168, Rome, Italy. Tel./fax: +39-06-30-5-81-81
e-mail: mgaudino{at}tiscalinet.it
| Abstract |
|---|
|
|
|---|
Key Words: C-reactive protein Coronary artery bypass
| 1. Introduction |
|---|
|
|
|---|
| 2. Patients and methods |
|---|
|
|
|---|
2.2. Operative technique
The anaesthetic procedures were standardized for all patients: they received their medication until the operative day and were premedicated with diazepam (0.15 mg/kg), morphine (0.15 mg/kg) and scopolamine (0.01 mg/kg). After induction with sodium thiopental (23 mg/kg) balanced anaesthesia was performed with isoflurane, fentanyl and boluses of midazolam and propofol as needed to maintain hypnosis.
Muscle relaxation was ensured by administration of pancuronium bromide (0.1 mg/kg). Anticoagulation was obtained with heparin 300 IU/kg and an activated clotting time >480 s. maintained. Heparin neutralization was achieved with prothamine hydrochloride 1.3 mg/mg heparin. All surgical procedures were performed in standard fashion by the same surgical team through median sternotomy, and using CPB. During CPB, the nasopharingeal temperature was kept at 37°C in 55 cases and at 26°C in 58. Myocardial protection was always accomplished by anterograde isothermic intermittent blood cardioplegia.
2.3. Postoperative evaluation
The clinical course of all patients, including major and minor postoperative complications, mean duration of mechanical ventilation and stay in the intensive care unit and in hospital were prospectively recorded. CRP, fibrinogen, interleukine 6 (IL-6), plasminogen activator inhibitor-1, prothrombin time, activated partial thromboplastin time, platelets and white blood cells counts were measured the day before surgery, 24, 48 and 72 h thereafter and at hospital discharge.
2.4. Measure and analysis method
All the blood samples were collected immediately before surgical operation, 24, 48 and 72 h after and at hospital discharge.
Plasmatic concentration of all the molecules considered were obtained as follows:
The remaining parameters (international normalized ratio (INR), activated partial thromboplastin time (aPTT), platelets and white blood cells counts) were measured in the hospital central laboratory and used for the clinical management before and after surgery.
2.5. Statistical analysis
Qualitative data were analysed by chi-square test. Quantitative data were expressed as mean±standard deviation (SD) of the mean and analysed by t test for independent samples. Quantitative repeated measurements data were analysed by two factor (time and treatment) analysis of variance (ANOVA) for repeated measures; post-hoc Newman Keuls test was performed if P<0.05. A P value <0.05 was considered significant.
With reference to preoperative levels of CRP, the population was divided into two groups: CRP>5 mg/l or CRP<5 mg/l (high and low group, respectively).
| 3. Results |
|---|
|
|
|---|
The time course of the dosed inflammatory and fibrinolytic markers in the overall population is summarized in Figs. 14 . As shown in Fig. 1, fibrinogen decreased in the first 24 h after surgery and then started rising until discharge (acting as a late acute phase protein), whereas PTT and INR had a similar pattern with a slight increase immediately after surgery followed by a substantial stability during the rest of the hospital stay. Fig. 2 depicts the PAI course: PAI activity peaked in the first postoperative hours and returned to baseline on the third postoperative day while PAI antigen showed two separate peaks, one 48 h after surgery and the second immediately before discharge. Interleukin-6 peaked in the first postoperative day and then gradually returned to baseline whereas CRP started rising from the second postoperative day and peaked 72 h after surgery (Fig. 3). Finally haematological values summarized in Fig. 4 showed that white blood cells, neutrophils and lymphocytes counts peaked immediately after the operation and then returned to baseline at the time of hospital discharge, monocytes had a biphasic time course with peaks 24 h after surgery and at discharge and platelets were significantly reduced after surgery and returned to baseline value only at the time of hospital discharge.
|
|
|
|
3.2. Group high vs. group low
3.2.1. Clinical data
Group high consisted of 31 patients vs. 82 of group low; the mean age was 61±8 vs. 62±10 years old. Concerning the preoperative risk factors 22 cases in group high had hypertension vs. 49 in group low, 5 vs. 18 were diabetics and 5 vs. 25 hypercholesterolemic. Eighteen patients in group high had a history of myocardial infarction and two suffered of heart failure vs. 39 and 3, respectively, in the group low. Left main coronary artery disease was present in five patients in group high vs. nine in group low. None of these differences was statistically significant.
Intraoperatively, CPB and cross-clamp time were also similar for the two groups (respectively, 75.37±20.6 vs. 74.9±18.8 and 62.5±21.7 vs. 61.8±16.8 min; P 0.92 and 0.85) as was the number of graft per patient (3.1±0.7 vs. 3.2±0.8; P=0.40).
The in-hospital clinical results were similar in both CRP groups. Particularly there were no differences regarding incidence of postoperative renal failure (1 vs. 0), assisted ventilation >24 h (6 vs. 1), inotropic drugs administration >24 h (0 vs. 0), need for blood transfusions (20 vs. 8), and need for surgical revision for bleeding (3 vs. 2). Two in-hospital deaths (1 vs. 1) occurred due to massive pulmonary embolism (on the third postoperative day) and myocardial infarction (8 days after surgery). Postoperatively, five patients experienced myocardial infarction (1 vs. 4), one patient had a septic syndrome (0 vs. 1) and two cases had to be reoperated for clinical or instrumental evidence of graft malfunction (0 vs.2). None of these differences was statistically significant.
Mean stay in intensive care and in-hospital after surgery in group high and low were 1.9±2.6 vs. 1.9 ±1.8 and 6.1±3.2 vs. 5.4±1.9 days, respectively (P=0.9 and 0.3).
3.2.2. Inflammatory markers trend analysis
The postoperative haematic inflammatory markers average in the two groups concentration trend is showed in Figs. 7 and 8. Average level of postoperative CRP in both CRP groups increased in the postoperative period with a peak concentration at 48 h for the high group; low group CRP levels grow up significantly slower than the group high and reached a significantly lower peak 24 h later. Elevated CRP levels were maintained until hospital discharge in both groups. The average values of IL-6, white blood cells, lymphocytes, neutrophils and monocytes showed small and non-significant differences between the two groups (see Figs. 7 and 8).
|
|
|
| 4. Discussion |
|---|
|
|
|---|
In view of these considerations, the possibility of predicting the hospital course of a patient by using a simple, relatively inexpensive and readily available markers such as the CRP would be of obvious interest.
Boralessa and associates in 1986 first suggested a possible predictive role of CRP in cardiac surgery patients: in a series of 25 patients undergoing coronary and valvular surgery these authors found that all cases with normal preoperative CRP levels recovered uneventfully, whereas the great majority of those with raised CRP values before surgery and persistent elevation after the operation experienced major postoperative complications [1]. These data were contradicted the following year by the observations of Kress et al. who, in a large cohort of 80 cardiac surgery cases could not confirm the predictive role of CRP with regard to the postoperative outcome [2].
However, more recently Boeken et al. retrospectively reviewed the files of a group of 50 patients undergoing coronary and valvular procedures with a preoperative CRP level >5 mg/l and compared their results with those of a cohort of 50 matched cases with a normal preoperative CRP value, finding a superior incidence of postoperative complications among the farmers [3]. As microbiological tests were negative, these authors attributed the more complicated postoperative course to the systemic inflammatory reaction to CPB and underscored the important prognostic value of CRP (suggesting even deferral of the operation in case of elevated preoperative level).
In our series no correlation could be established between the preoperative CRP value and the postoperative clinical course: both the type and incidence of major and minor postoperative complications were similar in the high and low groups. Although, as already described, the peak time and value and the pattern of normalization of CRP were different in the two series, other subtle markers of inflammation (such as IL-6 and the white blood cells count) were similar in the two patients groups (see Figs. 7 and 8 ).
|
The different results reported by Boralessa and Boeken [1,3], are probably related to the retrospective methodology used by the previous authors or the limited statistical power (as this is by far the largest study on this issue). Moreover in none of the previous series the entity of the systemic reaction to CPB was determined using sensible laboratory markers.
Finally, the evidence of a different postoperative pattern in platelets and fibrinogen levels (with higher values in the high series), although without any clinical correlation, might suggest a greater thrombotic attitude in patients with preoperative CRP>5 mg/l and should act as a stimulus for further investigation during the follow-up.
In conclusion, our data furnish substantial evidence that elevated preoperative CRP cannot be considered a marker of increased surgical risk and CRP level should not influence the decision process before cardiac surgery procedures.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Palmerini, A. Marzocchi, C. Marrozzini, L. B. Reggiani, C. Savini, G. Marinelli, R. Di Bartolomeo, and A. Branzi Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 685 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Ahlsson, L. Bodin, O. H. Lundblad, and A. G. Englund Postoperative Atrial Fibrillation is Not Correlated to C-Reactive Protein Ann. Thorac. Surg., April 1, 2007; 83(4): 1332 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cappabianca, D. Paparella, G. Visicchio, G. Capone, G. Lionetti, F. Numis, P. Ferrara, C. D'Agostino, and L. de Luca Tupputi Schinosa Preoperative C-Reactive Protein Predicts Mid-Term Outcome After Cardiac Surgery Ann. Thorac. Surg., December 1, 2006; 82(6): 2170 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hogue Jr, C. A. Palin, R. Kailasam, J. S. Lawton, A. Nassief, V. G. Davila-Roman, B. Thomas, and R. Damiano C-reactive protein levels and atrial fibrillation after cardiac surgery in women. Ann. Thorac. Surg., July 1, 2006; 82(1): 97 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Pascual, J. M. Arribas, P. L. Tornel, F. Marin, C. Oliver, M. Ahumada, J. Gomez-Plana, P. Martinez, R. Arcas, and M. Valdes Preoperative Statin Therapy and Troponin T Predict Early Complications of Coronary Artery Surgery Ann. Thorac. Surg., January 1, 2006; 81(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Biancari, J. Lahtinen, S. Lepojarvi, P. Rainio, E. Salmela, R. Pokela, M. Lepojarvi, J. Satta, and T. S. Juvonen Preoperative C-reactive protein and outcome after coronary artery bypass surgery Ann. Thorac. Surg., December 1, 2003; 76(6): 2007 - 2012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gaudino, F. Andreotti, R. Zamparelli, A. Di Castelnuovo, G. Nasso, F. Burzotta, L. Iacoviello, M. B. Donati, R. Schiavello, A. Maseri, et al. The -174G/C Interleukin-6 Polymorphism Influences Postoperative Interleukin-6 Levels and Postoperative Atrial Fibrillation. Is Atrial Fibrillation an Inflammatory Complication? Circulation, September 9, 2003; 108(90101): II-195 - 199. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |